Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Summit Corporation patents novel compounds with potential for Duchenne muscular dystrophy

March 19, 2009

Actelion Pharmaceuticals presents novel orexin receptor antagonists

March 19, 2009

Merck Serono and Fast Forward to accelerate development of MS treatments

March 19, 2009

Cephalon reports positive results from phase II Nuvigil study

March 19, 2009

Questcor submits sNDA to FDA for H.P. Acthar gel for infantile spasms

March 19, 2009

Preliminary data show effects on sleep and memory with ramelteon in Parkinson's disease patients

March 19, 2009

NST-0021 prevents neurodegeneration in vivo in Alzheimer's model

March 19, 2009

Pimavanserin does not worsen parkinsonism in patients with PD and psychosis

March 19, 2009

CytRx's arimoclomol improves stroke recovery in preclinical trial in rats

March 18, 2009

Memantine beneficial in patients with Parkinson's disease dementia or dementia with Lewy bodies

March 18, 2009

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...